We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$349B
AUM Growth
+$31.1B
Cap. Flow
+$7.21B
Cap. Flow %
2.07%
Top 10 Hldgs %
18.28%
Holding
8,254
New
342
Increased
3,908
Reduced
2,518
Closed
710

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Technology 11.68%
3 Healthcare 9.18%
4 Industrials 8.18%
5 Energy 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
7276
Immunic
IMUX
$226M
$0 ﹤0.01%
15
-100
-87% -$2.73K
INAB icon
7277
IN8bio
INAB
$11.6M
-5
Closed
INM icon
7278
InMed Pharmaceuticals
INM
$7.64M
$0 ﹤0.01%
+1
New +$67
INOD icon
7279
Innodata
INOD
$2.03B
-296
Closed -$1K
INTR icon
7280
Inter&Co
INTR
$2.3B
-1
Closed
INUV icon
7281
Inuvo
INUV
$14.2M
$0 ﹤0.01%
11
+1
+10% +$3
INZY
7282
DELISTED
Inozyme Pharma
INZY
-690
Closed -$2K
HYFT
7283
MindWalk Holdings
HYFT
$65.3M
$0 ﹤0.01%
50
-250
-83% -$1.27K
IPHA
7284
Innate Pharma
IPHA
$239M
$0 ﹤0.01%
125
-52
-29% -$118
IPOS icon
7285
Renaissance International IPO ETF
IPOS
$11.8M
$0 ﹤0.01%
26
IPW icon
7286
iPower
IPW
$712K
0
IRIX icon
7287
IRIDEX
IRIX
$14.3M
-41
Closed
IRON icon
7288
Disc Medicine
IRON
$3.07B
-4
Closed
ITRG
7289
Integra Resources
ITRG
$550M
$0 ﹤0.01%
358
+124
+53% +$192
ITRN icon
7290
Ituran Location and Control
ITRN
$1.06B
-1
Closed
IZEA icon
7291
IZEA Worldwide
IZEA
$53.8M
-59
Closed
JAGX icon
7292
Jaguar Health
JAGX
$3.85M
0
JANW icon
7293
AllianzIM U.S. Equity Buffer20 Jan ETF
JANW
$351M
-3,000
Closed -$74K
JBLU icon
7294
PUT
JetBlue
JBLU
$2.19B
-70,000
Closed -$464K
NEXR
7295
Nexera Technologies Ltd
NEXR
$1.53M
0
-$1K
JIG icon
7296
JPMorgan International Growth ETF
JIG
$508M
-2,976
Closed -$140K
JMUB icon
7297
JPMorgan Municipal ETF
JMUB
$8.52B
-131
Closed -$6K
JNUG icon
7298
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$516M
$0 ﹤0.01%
7
JPME icon
7299
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$479M
-447
Closed -$34K
JPRE icon
7300
JPMorgan Realty Income ETF
JPRE
$479M
$0 ﹤0.01%
1

Similar funds

Royal Bank of Canada's Q4 2022 Portfolio in Review

As of Q4 2022, Royal Bank of Canada held 8,254 positions worth $349B, up 9.8% from $318B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Royal Bank of Canada's Q4 2022 filing shows 342 new, 3,908 increased, 2,518 reduced and 710 closed positions. Its largest new stake was Brookfield Asset Management: 22,158,258 shares worth $635M. The largest sale was Enbridge, an estimated $955M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Royal Bank of Canada's largest Q4 2022 buy was Brookfield Asset Management: 22,158,258 shares worth $635M.
  • Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $673M increase.
  • Royal Bank of Canada's biggest Q4 2022 reduction was Enbridge, cutting an estimated $955M.
  • Royal Bank of Canada fully exited Switch, Inc. Class A Common Stock in Q4 2022, selling an estimated $396M.
  • Royal Bank of Canada's ten largest holdings make up 18% of its $349B portfolio in Q4 2022.
  • Royal Bank of Canada opened 342 new positions and closed 710 in Q4 2022.
  • Royal Bank of Canada's portfolio value rose 9.8% quarter-over-quarter to $349B.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.